Timing
Purchase and sale flow
PurchasesSales
Stock, pipeline and biotech catalyst intelligence
Reported ownership activity
Activity signal
Reported sales exceed purchases by $54.8KOption exercises, awards, and grants are separated from open-market direction.Timing
Composition
Concentration
Company profile
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
| Insider trading | Relationship | Date | Transaction | Cost | Shares | Value | Shares total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Sun Nelson | Chief Financial Officer | Dec 11 '25 | Buy | $14.40 | 3,000 | $43,200 | 108,484 | Dec 12 08:30 PM |
| Lee Tien-li | Chief Executive Officer | Dec 11 '25 | Buy | $14.48 | 7,000 | $101,395 | 1,551,613 | Dec 12 08:30 PM |
| Lee Tien-li | Chief Executive Officer | Oct 15 '25 | Option Exercise | $4.24 | 1,229 | $5,211 | 1,544,613 | Oct 16 06:14 PM |
Transactions may include sales, purchases, grants, and option exercises. Directional charts count only purchases and sales; follow the Form 4 link to verify the original SEC filing.